GRIM-19与泌尿男生殖系肿瘤发生发展关系的研究进展

doi:10.13481/j.1671-587x.20200437

[1] ANGELL J E, LINDNER D J, SHAPIRO P S, et al. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach[J].J Biol Chem, 2000, 275(43):33416-33426.
[2] NALLAR S C, KALVAKOLANU D V. GRIM-19:a master regulator of cytokine induced tumor suppression, metastasis and energy metabolism[J]. Cytokine Growth Factor Rev, 2017, 33:1-18.
[3] KONG D X, CHEN J Y, SUN X, et al. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling[J]. Biosci Trends, 2019, 13(4):342-350.
[4] ASHIZAWA Y, KUBOKI S, NOJIMA H, et al. OLFM4 enhances STAT3 activation and promotes tumor progression by inhibiting GRIM19 expression in human hepatocellular carcinoma[J]. Hepatol Commun, 2019, 3(7):954-970.
[5] ZHANG J, CHU D K, KAWAMURA T, et al. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis[J]. J Cell Physiol,2019,234(8):12800-12808.
[6] LI F, QI J, QIN C, et al. Taurolidine promotes cell apoptosis by enhancing GRIM-19 expression in liver cancer[J]. Oncol Rep, 2018,40(6):3743-3751.
[7] CHEN W H, LIU Q B, FU B, et al. Overexpression of GRIM-19 accelerates radiation-induced osteosarcoma cells apoptosis by p53 stabilization[J]. Life Sci, 2018, 208:232-238.
[8] SONG J X, SHI W D, WANG W C, et al. Grim-19 expressed by recombinant adenovirus for esophageal neoplasm target therapy[J]. Mol Med Rep, 2018, 17(5):6667-6674.
[9] ILELIS F, DO AMARAL N S, ALVES M R, et al. Prognostic value of GRIM-19, NF-κB and IKK2 in patients with high-grade serous ovarian cancer[J]. Pathol Res Pract, 2018, 214(2):187-194.
[10] WU N, HUI H Y, CUI L, et al. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling[J]. Biomed Pharmacother,2017, 95:1169-1176.
[11] REN M, WANG Y, WU X D, et al. Curcumin synergistically increases effects of β-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3-dependent and STAT3-independent pathways[J]. J Drug Target, 2017, 25(3):247-254.
[12] LUFEI C C, MA J, HUANG G C, et al. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction[J]. EMBO J, 2003, 22(6):1325-1335.
[13] ZHANG X W, HUANG Q, YANG Z H, et al. GW112, a novel antiapoptotic protein that promotes tumor growth[J]. Cancer Res, 2004, 64(7):2474-2481.
[14] LU H, CAO X M. GRIM-19 is essential for maintenance of mitochondrial membrane potential[J]. Mol Biol Cell, 2008, 19(5):1893-1902.
[15] MÁXIMO V,BOTELHO T,CAPELA J,et al. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid[J]. Br J Cancer,2005,92(10):1892-1898.
[16] SUN P, NALLAR S C, KALAKONDA S, et al. GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring[J]. Oncogene, 2009, 28(10):1339-1347.
[17] 刘艳波, 沈维高, 葛贺, 等. survivin和GRIM-19在前列腺癌组织中的表达[J]. 中华男科学杂志, 2011, 17(1):21-26.
[18] 邵月婷, 张灵, 汲坤, 等. GRIM-19基因的克隆及其对小鼠前列腺癌细胞株的促凋亡作用[J]. 基础医学与临床, 2008, 28(1):13-17.
[19] 梁作文, 赵丽晶, 贾慧婕, 等. 共表达siRNA-Stat3与GRIM-19质粒的构建及其功能研究[J]. 吉林大学学报(医学版), 2010, 36(5):858-861.
[20] 刘艳波, 葛贺, 盖晓东, 等. GRIM-19基因对前列腺癌DU145细胞的促凋亡作用[J]. 北华大学学报(自然科学版), 2012, 13(1):58-61.
[21] 沈维高, 赵丽晶, 盖晓东, 等. siRNA-survivin与GRIM-19共表达质粒的构建及其对前列腺癌DU145细胞生长的抑制作用[J]. 中国病理生理杂志, 2012, 28(7):1241-1246.
[22] 赵晓晖, 芦丽莉, 葛贺, 等. 携带pGRIM-19-si-survivin共表达质粒的减毒沙门菌对前列腺癌移植瘤的体内抑制作用[J]. 中国病理生理杂志, 2014, 30(6):961-967.
[23] SHAO Y, LIU Y, SHAO C, et al. Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein[J]. Cancer Gene Ther, 2010, 17(12):844-854.
[24] ZHANG L, GAO L F, LI Y, et al. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth[J]. Clin Cancer Res, 2008, 14(2):559-568.
[25] 邵月婷,高丽芳,孙连坤,等.ATRA联合IFN-α对PC-3细胞株的生长抑制作用以及对GRIM-19和STAT3基因表达的影响[J].肿瘤,2006,26(3):228-231.
[26] 邵月婷,李峰,高丽芳,等.人参皂苷Rh2诱导PC-3M细胞凋亡及其对新基因GRIM-19表达的影响[J].吉林大学学报(医学版),2006,32(2):186-193.
[27] 刘亚男,邵月婷,李晓洁,等.尾叶香茶菜二萜类化合物B对小鼠前列腺癌细胞细胞周期的影响及其机制[J].中国病理生理杂志,2008,24(10):1916-1921.
[28] ALCHANATI I, NALLAR S C, SUN P, et al. A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas[J]. Oncogene, 2006, 25(54):7138-7147.
[29] LIN H L, LIN T Q, LIN J G, et al. Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19[J]. Gene, 2019, 688:93-97.
[30] HE X L, CAO X M. Identification of alternatively spliced GRIM-19 mRNA in kidney cancer tissues[J]. J Hum Genet, 2010, 55(8):507-511.
[31] 汲坤, 王波, 李馨, 等. 细胞死亡调节因子GRIM-19蛋白在肾脏透明细胞癌组织中的表达及意义[J]. 吉林大学学报(医学版), 2009, 35(1):146-149, 197.
[32] 裴隆.STAT3、p-STAT3与GRIM-19在肾癌中的表达及意义[D].石家庄:河北医科大学,2012.
[33] CUI L G, MENG Q J, WEN J G, et al. The effect of a gene associated with retinoid-interferon-induced mortality 19(GRIM-19) on STAT3-induced gene expression in renal carcinoma[J]. J Biochem, 2018, 164(4):285-294.
[34] 彭晓晖, 梁培育, 欧善际, 等. 膀胱癌组织中GRIM-19及其靶基因产物STAT3的表达及其相关性的研究[J]. 海南医学院学报, 2013, 19(9):1201-1203, 1207.
[35] 彭晓晖, 梁培育, 欧善际, 等. GRIM-19的表达与膀胱癌组织临床特征的相关性研究[J]. 海南医学院学报, 2013, 19(10):1372-1374.
[36] 曹正国, 田超, 黎建欣, 等. GRIM-19在人膀胱尿路上皮癌中的表达及其与p63、STAT3的相关性研究[J]. 现代泌尿生殖肿瘤杂志, 2014, 6(6):351-355.
[37] NI F, YAN C Y, ZHOU S, et al. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation[J]. Cancer Chemother Pharmacol, 2018, 82(4):593-605.
[38] HARIRI J. Müllerian adenosarcoma of the endometrium:review of the literature and report of two cases[J]. Int J Gynecol Pathol,1983,2(2):182-191.
[39] MARCO V,FORCADA P. Mesonephric adenosarcoma of the renal pelvis with heterologous elements[J]. Am J Surg Pathol,1985,9(8):610-614.
[40] 刘随, 刘斌, 金汶, 等. 鲍温病及佩吉特病患者皮损中GRIM19表达水平的研究[J]. 西部医学, 2018, 30(2):170-173.

Research progress in relationship between GRIM-19 and occurrence and development of urogenital reproductive neoplasms

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	KONG Wencong, HE Wubin, SU Rongjian, JIA Daqi, GU Yanjiao, WANG Yue, DU Xiaoyuan. Inhibitory effect and apoptosisinduction of MST1R inhibitor BMS-777607 on proliferation of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 451-457.
[2]	XU Fengying, LIU Ru, MA Li, QU Yifan, XIAO Weili, WANG Yuzhen, XIE Jiming. Network analysis on Rab7a gene in breast cancer MDA-MB-231 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 464-469.
[3]	WEN Qingyi, JIAO Miaomiao, XIE Xiao, PEN Jingyu, DONG Fengge, WEI Xue, YANG Ming. Inhibitory effect of disulfiram combined with cisplatin on triple negative breast cancer MDA-MB-231 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 523-529.
[4]	FENG Lei, ZHANG Hante, LI Xiang, MENG Fanping, LI Yan. Promotion effect of IL-4 and estradiol on growth of breast cancer cells in mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 536-542.
[5]	GUO Xiaofei, LIU Lihong, AI Hao. Expression of valosin-containing protein in epithelial ovarian cancer tissue and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 600-606.
[6]	. Research progress in clinical application of Raman spectroscopyin breast cancer [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 413-418.
[7]	NIE Man, YUE Jun. Effects of TP53 G199X and V157fs on function of ovarian cancer A2780 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 292-296.
[8]	CHEN Zhouhua, GONG Hui, FENG Lei, XIAO Yujie, HUANG Lizhong. Induction of LPS on epithelial mesenchymal transition in breast cancer MDA-MB-231 cells and its effect on β-catenin expression [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 309-315.
[9]	LI Songyan, LIN Dongjing, YU Yang, LIU Shibing, XU Lu, SUN Qi, XU Ye. Effect of silencing sirtuin 3 on resveratrol-induced apoptosis of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 45-49.
[10]	LIU Xiuhua, WANG Man, DONG Xinjie, LIU Jingnan, HAN Wei, GUAN Yinghui. Expression of filamin A in cancer tissue of cervical cancer patients and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1238-1242.
[11]	ZHU Zhongbo, QIAN Jiansheng, YANG Shuo, LI Kangle, DOU Jianwei. Inhibitory effect of different doses of ¹²⁵I seed implantation on tumor-bearing proliferation in nude mice with breast cancer and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1305-1309.
[12]	ZHOU Chun, WANG Guanghua, ZHANG Bangzhu. Effects of miR-367 on proliferation, invasion and migration of human breast cancer MCF-7 cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1353-1360.
[13]	YANG Zhuangqing, LU Mei, YANG Xiaojuan, WANG Chang'an, ZOU Jieya. Inhibitory effect of inhibiting TRIM24 gene expression on proliferation, apopotosis,invasion and migration of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1379-1383.
[14]	TANG Geng, SHI Yaoting, KONG Weixuan, KE Xiyang, LI Chengxiang, QIU Yuqi, YU Lei, YANG Yanming, WANG Zhicheng. Effect of ionizing radiation on DNA damage repair in HeLa cells silencing ATRX [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 981-985.
[15]	YU Xiuyan, WAN Guangcai, SUN Hongshuai, ZHU Hua, GAO Haiyan, WU Xuefeng. Relationship between fibrinogen and prognosis of breast cancer patients:A Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1092-1097.